A promising antitumor method: Targeting CSC with immune cells modified with CAR

Area of Science:

• Oncology
• Immunotherapy
• Cancer Stem Cell Biology

Background:

• Cancer stem cells (CSCs) drive tumor formation, metastasis, and recurrence.
• Targeting CSCs is crucial for effective cancer treatment.
• Existing CSC inhibition methods include antibodies, inhibitors, and differentiation therapy.

Purpose of the Study:

• To review current CSC targets for inhibition.
• To summarize CAR-engineered immune effector cells for CSC therapy.
• To discuss challenges and future directions in CAR-based CSC immunotherapy.

Main Methods:

• Review of literature on CSC targets.
• Analysis of CAR-engineered T cells, NK cells, and macrophages for CSC therapy.
• Discussion of dual-targeting strategies and CAR-NK cell potential.

Main Results:

• Identified various CSC targets and CAR-based immunotherapy approaches.
• Highlighted the potential of CAR-NK cells in CSC treatment.
• Proposed dual-targeting strategies for enhanced efficacy.

Conclusions:

• CAR-based immunotherapy offers a promising avenue for targeting CSCs.
• CAR-NK cells show significant potential for CSC therapy.
• Dual-targeting strategies and further research are needed for optimal CAR immunotherapy in cancer treatment.